Ascendis Pharma · 23 hours ago
Finance Operations Associate - Temporary Contract - Job ID: FOAC
Princeton, NJ
Full-time, Contract
Onsite
Entry Level
$35/hr - $40/hr
1+ years expAscendis Pharma is a dynamic, fast-growing global biopharmaceutical company advancing programs in Endocrinology Rare Disease and Oncology. The Finance Operations Associate will support various financial operations including invoice processing, expense management, and purchase order processes while ensuring compliance with financial policies.
BiotechnologyClinical TrialsHealth Care
Responsibilities
Support processing invoices and ensuring compliance with financial policies and procedures
Support Expense Management including auditing, accruals, and providing training and support to the business
Support with Expense Management mailboxes
Support Purchase Order Process including creation, maintenance, and training
Support Corporate Credit Card process including issuance, maintenance and error handling
Qualification
Required
1-3 years of related experience with a Bachelor's Degree in Accounting or a related field of study
Experience with IFRS, with detailed understanding of accounting methods, reporting, bookkeeping, reconciliations, and revenue recognition
Strong analytical, proactive problem-solving skills, and collaboration skills critical to the role
Highest standards of accuracy and precision; extremely organized, detail-oriented, and mindful of deadlines
Excellent verbal and written communication skills, with the ability to articulate issues and solutions to all levels of management
Excellent interpersonal skills and the ability to work effectively with multiple functional areas in a collaborative, team environment
Preferred
Experience within Pharma/Biotech industry is preferred
Experience with ERP and accounting system, preferably D365
Company
Ascendis Pharma
Ascendis Pharma built a high-value pipeline that aims to change the clinical treatment paradigms.
1001-5000 employees
Funding
Current Stage
Public CompanyTotal Funding
$1.88BKey Investors
Royalty Pharma
2024-09-19Post Ipo Equity· $300M
2024-09-03Post Ipo Debt· $150M
2023-09-05Post Ipo Debt· $150M
Leadership Team
Ivanna Rosendal
Senior Director, IT Business Partner
Keren Tenenbaum
US General Counsel and Chief Compliance Officer
Recent News
2026-01-11
2026-01-11
Company data provided by crunchbase